EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma

Kamal Hammouda, Naoto Tokuyama, Germán Corredor, Tilak Pathak, Rishi Dakarapu, Elizabeth Genega, Omar Y Mian, Paul G Pavicic, C Marcela Diaz-Montero, Tuomas Mirtti, Xavier Farré, Shilpa Gupta und 1 weitere

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.218059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Kamal Hammouda und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, GA, USA; Mathematics Department, Faculty o…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Urinary Bladder Neoplasms, Artificial Intelligence, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSRD VA, BLRD VA, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urothelial carcinoma (UC) is one of the leading causes of cancer-related mortality, and effective, scalable biomarkers for treatment planning remain limited. We present UC-TIL, an artificial intelligence (AI)-based model that quantifies spatial patterns of tumor-infiltrating lymphocytes (TILs) from routine H&E-stained slides to predict survival and immunotherapy response. We analyzed 558 whole-slide images across three cohorts: TCGA (D0&1, N = 292), Emory (D2, N = 161), and TRRC2819 (D3, N = 105), spanning chemotherapy and immune checkpoint inhibitor (ICI) treatments. UC-TIL classification was associated with OS (HR = 2.11, 95 %CI:1.01-4.41, p = 0.011) and PFS (HR = 3.68, 95 %CI:1.07-12.65, p = 0.0012) in locally advanced disease (D1 and D2), with consistent results in metastatic disease (D3) (HR = 1.73, 95 %CI:1.08-2.77, p = 0.043; PFS HR = 1.73, 95 %CI:1.07-2.81, p = 0.047). In the ICI-treated D3 cohort, UC-TIL achieved AUC = 0.757 and identified non-responders with 91 % specificity. UC-TIL enables reliable risk stratification and treatment response prediction in both locally advanced and metastatic urothelial carcinoma by analyzing spatial TIL patterns from standard pathology slides. These findings position UC-TIL as a readily deployable tool to guide personalized therapy across multiple clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingUrinary Bladder NeoplasmsArtificial IntelligenceCarcinoma, Transitional CellHumansMaleImmune Checkpoint InhibitorsFemaleAgedPrognosisMiddle AgedTreatment OutcomeNeoplasm Invasiveness

Stichwörter der Autor:innen

Artificial intelligenceDigital pathologyMetastatic urothelial carcinomaMuscle-invasive bladder cancerPredictive biomarkerTumor-infiltrating lymphocytes

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, GA, USA; Mathematics Department, Faculty of Science, Mansoura University, Mansoura, Egypt; Atlanta Veterans Affa…
  • The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, GA, USA; Tokyo Medical University, Department of Urology, Tokyo, Japan.
  • The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, GA, USA; Atlanta Veterans Affairs Medical Center, Atlanta, GA, USA.
  • The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, GA, USA.
  • Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Cleveland Clinic, Cleveland, OH, USA.

Förderung

  • CSRD VA
  • BLRD VA
  • NIDDK NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • ARPA-H
  • Department of Veterans Affairs
  • U.S. Department of Defense

Zitieren

APA

Hammouda, K., Tokuyama, N., Corredor, G., Pathak, T., Dakarapu, R., Genega, E., Mian, O. Y., Pavicic, P. G., Diaz-Montero, C. M., Mirtti, T., Farré, X., Gupta, S., & Madabhushi, A. (2025). AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.218059

Vancouver

Hammouda K, Tokuyama N, Corredor G, Pathak T, Dakarapu R, Genega E, et al. AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.218059

BibTeX
@article{Hammouda2025,
  author = {Hammouda, Kamal and Tokuyama, Naoto and Corredor, Germán and Pathak, Tilak and Dakarapu, Rishi and Genega, Elizabeth and Mian, Omar Y and Pavicic, Paul G and Diaz-Montero, C Marcela and Mirtti, Tuomas and Farré, Xavier and Gupta, Shilpa and Madabhushi, Anant},
  title = {AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.218059}
}
Kostenlos starten →